Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Ann Dermatol Venereol ; 146(4): 265-272, 2019 Apr.
Article in French | MEDLINE | ID: mdl-30833038

ABSTRACT

BACKGROUND: The prevalence of psoriasis among patients presenting human immunodeficiency virus (HIV)infection is the same as in the general population, but the disease is more severe and refractory, and management is more complex. The aim of this survey was to assess the practices of French dermatologists concerning both screening for HIV in psoriasis patients and therapeutic management and follow-up of psoriasis patients with HIV. PATIENTS AND METHODS: An anonymous national survey of practices was conducted by means of a questionnaire emailed to dermatologists in hospital in private practice in France between March and June 2017. RESULTS: The questionnaire was completed by 262 dermatologists. They indicated that they carried out screening for HIV in psoriasis patients presenting risk factors (79.4%), prior to biotherapy (63.4%) or different systemic treatments other than retinoids (53.1%), if the psoriasis was severe (45.8%), or in the event of worsening (37.8%). 28.7% of practitioners surveyed were in fact treating patients with psoriasis and HIV, with a mean 3.1 patients being followed up. All practitioners prescribe systemic treatment, other than cyclosporine, but they frequently consult an infectious disease specialist before prescribing these therapies. The most widely used biotherapy was etanercept (65.5% of practitioners). More intensive laboratory follow-up was conducted for these patients in 72.1% of cases. CONCLUSION: French dermatologists do not perform routine screening for HIV in psoriasis patients. However, where infection has been identified, their practices are modified accordingly. Therapeutic choices are consistent with the French recommendations. Nevertheless, recommendations appear necessary concerning HIV screening in this population.


Subject(s)
HIV Seropositivity/diagnosis , Psoriasis/diagnosis , Adult , Biological Therapy , Cross-Sectional Studies , Etanercept/therapeutic use , Female , Follow-Up Studies , HIV Seropositivity/epidemiology , HIV Seropositivity/therapy , Humans , Interdisciplinary Communication , Intersectoral Collaboration , Male , Mass Screening , Middle Aged , Psoriasis/epidemiology , Psoriasis/therapy , Referral and Consultation , Risk Factors , Surveys and Questionnaires
2.
Drug Alcohol Depend ; 192: 8-15, 2018 11 01.
Article in English | MEDLINE | ID: mdl-30195243

ABSTRACT

BACKGROUND: Contingency management (CM) is an evidence-based intervention providing rewards in exchange for biomarkers that confirm abstinence from stimulants such as methamphetamine. We tested the efficacy of a positive affect intervention designed to boost the effectiveness of CM with HIV-positive, methamphetamine-using sexual minority men. METHODS: This attention-matched, randomized controlled trial of a positive affect intervention delivered during CM was registered on www.clinicaltrials.gov (NCT01926184). In total, 110 HIV-positive sexual minority men with biologically confirmed, recent methamphetamine use were enrolled. Five individual sessions of a positive affect intervention (n = 55) or an attention-control condition (n = 55) were delivered during three months of CM. Secondary outcomes examined over the 3-month intervention period included: 1) psychological processes relevant to affect regulation (i.e., positive affect, negative affect, and mindfulness); 2) methamphetamine craving; 3) self-reported stimulant use (past 3 months); and 4) cumulative number of urine samples that were non-reactive for stimulants (i.e., methamphetamine and cocaine) during CM. RESULTS: Those randomized to the positive affect intervention reported significant increases in positive affect during individual sessions and increases in mindfulness over the 3-month intervention period. Intervention-related improvements in these psychological processes relevant to affect regulation were paralleled by concurrent decreases in methamphetamine craving and self-reported stimulant use over the 3-month intervention period. CONCLUSIONS: Delivering a positive affect intervention may improve affect regulation as well as reduce methamphetamine craving and stimulant use during CM with HIV-positive, methamphetamine-using sexual minority men.


Subject(s)
Amphetamine-Related Disorders/psychology , Amphetamine-Related Disorders/therapy , Early Intervention, Educational/methods , Homosexuality, Male/psychology , Methamphetamine , Sexual and Gender Minorities/psychology , Adult , Amphetamine-Related Disorders/urine , Behavior Therapy/methods , Central Nervous System Stimulants/urine , Follow-Up Studies , HIV Seropositivity/psychology , HIV Seropositivity/therapy , HIV Seropositivity/urine , Humans , Male , Methamphetamine/urine , Middle Aged , Mindfulness/methods , Reward
3.
J Homosex ; 62(5): 571-87, 2015.
Article in English | MEDLINE | ID: mdl-25492304

ABSTRACT

In the last four decades, we have witnessed vast and important transitions in the social, economic, political, and health contexts of the lived experiences of gay men in the United States. This dynamic period, as evidenced most prominently by the transition of the gay rights movement to a civil rights movement, has shifted the exploration of gay men's health from one focusing primarily on HIV/AIDS into a mainstream consideration of the overall health and wellbeing of gay men. Against this backdrop, aging gay men in the United States constitute a growing population, for whom further investigations of health states and health-related disparities are warranted. In order to advance our understanding of the health and wellbeing of aging gay men, we outline here a multilevel, ecosocial conceptual framework that integrates salient environmental, social, psychosocial, and sociodeomgraphic factors into sets of macro-, meso-, and micro-level constructs that can be applied to comprehensively study health states and health care utilization in older gay men.


Subject(s)
Aging/psychology , Holistic Health/trends , Homosexuality, Male/psychology , Adult , Aged , Forecasting , HIV Seropositivity/psychology , HIV Seropositivity/therapy , Health Services Accessibility/statistics & numerical data , Health Services Needs and Demand/trends , Health Status Disparities , Healthcare Disparities/trends , Homophobia/psychology , Humans , Male , Middle Aged , Quality of Life/psychology , Social Change , Social Stigma , United States
4.
Complement Ther Med ; 22(2): 400-8, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24731912

ABSTRACT

BACKGROUND: This cross-sectional study investigated whether the theory of planned behavior (TPB) constructs: attitudes, subjective norms, and perceived behavioral control were related to intention of dietary supplements use among African-American women living with Human Immunodeficiency Virus and/or Acquired Immune Deficiency Syndrome (HIV/AIDS). METHODS: A closed-ended questionnaire based on the TPB was utilized to explore the use of dietary supplements among a cohort of 153 HIV-positive African-American women. RESULTS: Overall, 45% of the respondents used dietary supplements to manage/control their HIV. Combined, attitudes, subjective norms and perceived behavioral control were significant predictors of intention toward dietary supplement use (69% of the variance explained, p<0.0001). Attitudes (ß=0.23, p<0.001) and perceived behavioral control (ß=0.45, p<0.0001) were found to be significant independent predictors of intention. Behavioral intention and proximal TPB constructs (attitudes, subjective norms, and perceived behavioral control), as well as their underlying beliefs about dietary supplements use, were all found to be significantly more positive in users of dietary supplements compared to non-users (p<0.001). CONCLUSIONS: Results showed that attitudes, subjective norms and perceived behavioral control are important predictors in the intention to use dietary supplements for control of HIV among African-American women. Implications from this study suggest that the TPB can be used to better identify and understand salient beliefs that surround intentions to use alternative therapies for management of disease. These beliefs can be used to develop interventions surrounding HIV treatment and care.


Subject(s)
Black or African American/statistics & numerical data , Dietary Supplements , HIV Seropositivity , Health Knowledge, Attitudes, Practice , Adult , Aged , Complementary Therapies , Cross-Sectional Studies , Female , HIV Seropositivity/epidemiology , HIV Seropositivity/psychology , HIV Seropositivity/therapy , Humans , Linear Models , Middle Aged , Surveys and Questionnaires
5.
AIDS Care ; 26(8): 1027-31, 2014.
Article in English | MEDLINE | ID: mdl-24617706

ABSTRACT

The Affordable Care Act (ACA) creates incentives to coordinate primary care, mental health (MH) care, and addiction services. Integration of clinical HIV and MH services has been shown to improve quality of life and physical and MH of people living with HIV/AIDS. However, few studies have investigated the practice of service integration systematically. We examined the practice patterns of 515 direct service providers in New York State who received training about HIV MH between May 2010 and July 2012. We sought to identify provider and treatment setting characteristics associated with an integrated spectrum of care. Using factor analysis and linear modeling, we found that patterns of service integration varied by type of health-care setting, service setting location, providers' HIV caseload, and the discipline of the provider describing the direct services. Understanding the existing capacities of clinicians providing care in a variety of settings throughout New York will help to guide staffing and linkage to enhance HIV MH service integration as significant shifts in the organization of health care occur.


Subject(s)
Delivery of Health Care, Integrated , HIV Seropositivity/psychology , Mental Health Services/organization & administration , Patient Protection and Affordable Care Act , Primary Health Care/organization & administration , Quality of Health Care , Factor Analysis, Statistical , HIV Seropositivity/therapy , Humans , Linear Models , Mental Health , Models, Organizational , New York/epidemiology , Practice Patterns, Physicians' , Qualitative Research , Quality of Life
6.
J Int Assoc Provid AIDS Care ; 13(4): 318-23, 2014.
Article in English | MEDLINE | ID: mdl-23715264

ABSTRACT

PURPOSE: Activation of the hypothalamic-pituitary-adrenal axis, assessed in terms of cortisol levels, may enhance the ability of HIV to infect lymphocytes and downregulate the immune system, accelerating disease progression. This study sought to determine the effects of relaxation techniques on cortisol levels in HIV-seropositive women. METHODS: Women (n = 150) were randomized to a group cognitive-behavioral stress management (CBSM) condition or an individual information condition and underwent 3 types of relaxation training (progressive muscle relaxation, imagery, and autogenic training). Cortisol levels were obtained pre- and postrelaxation. RESULTS: Guided imagery was effective in reducing cortisol in the group condition (t = 3.90, P < .001), and muscle relaxation reduced cortisol in the individual condition (t = 3.1 I, P = .012). Among participants in the group condition attending all sessions, the magnitude of pre- to postsession reduction became greater over time. CONCLUSIONS: Results suggest that specific relaxation techniques may be partially responsible for cortisol decreases associated with relaxation and CBSM.


Subject(s)
Cognitive Behavioral Therapy , HIV Seropositivity/metabolism , Hydrocortisone/metabolism , Relaxation Therapy , Stress, Psychological/metabolism , Stress, Psychological/prevention & control , Adult , Autogenic Training , Female , HIV Seropositivity/psychology , HIV Seropositivity/therapy , Humans , Imagery, Psychotherapy , Middle Aged , Muscle Relaxation
7.
Rev. bras. enferm ; 66(6): 887-892, nov.-dez. 2013.
Article in Portuguese | LILACS, BDENF - Nursing | ID: lil-699933

ABSTRACT

A detecção da positividade para o HIV, durante o trabalho de parto, por meio dos testes rápidos, fragiliza as mulheres e gera demandas específicas de cuidados. Este estudo objetivou analisar o cuidado profissional a mulheres com teste rápido positivo para HIV a partir do olhar de mulheres que tomaram conhecimento da positividade durante o trabalho de parto ou puerpério. Trata-se de estudo do tipo exploratório, com abordagem qualitativa. Os dados foram coletados por meio de entrevista semiestruturada e analisados por meio da técnica de análise de discurso. Observou-se que as relações de cuidado às mulheres com teste rápido positivo para HIV se distanciam da integralidade, uma vez que se mantêm distantes e superficiais, sendo norteadas pelo modelo biomédico. A incorporação da perspectiva da integralidade nas ações de saúde exige reflexão por parte do(a)s profissionais, do(a)s gestore(a)s do sistema público de saúde, bem como a capacitação desse(a)s profissionais.


The positive detection during partum labor makes women weak and generates specific care demands. The aim of this research was to analyze professional care to women with positive result from fast HIV test based on the point of view of women who knew the positive result during partum labor or postpartum. This is an exploratory study with a qualitative approach. Data were collected through semi-structured interviews and analyzed using the discourse analysis technique. It was observed that the relations of care for women with positive rapid HIV test are far away from integrality, since they remain distant and superficial, being guided by the biomedical model. The mainstreaming of integrality in health care requires consideration by the professional, public health system managers, as well as training of those professionals.


La detección de seropositividad durante el trabajo de parto debilita las mujeres y genera demandas específicas de atención. El estudio objetivó analizar la atención profesional a las mujeres con resultado positivo para el VIH, desde la mirada de las mujeres que se enteraron de la seropositividad durante el trabajo de parto o el puerperio. El estudio es de carácter exploratorio con un abordaje cualitativo. Los datos fueron recolectados a través de entrevistas semi-estructuradas y analizadas con la técnica del análisis del discurso. Fue observado que las relaciones de atención a las mujeres seropositivas para el VIH se distancian de la integralidad, ya que se mantienen alejadas y superficiales, siendo guiado por el modelo biomédico. La incorporación de la perspectiva de la integralidad en las acciones de salud requiere una reflexión por parte de los profesionales, de los administradores del sistema de salud pública, además de la capacitación de estos profesionales.


Subject(s)
Female , Humans , Pregnancy , HIV Seropositivity/therapy , Patient Satisfaction , Delivery of Health Care, Integrated , HIV Seropositivity/diagnosis , Peripartum Period , Postpartum Period
8.
Rev Bras Enferm ; 66(6): 887-92, 2013 Dec.
Article in Portuguese | MEDLINE | ID: mdl-24488461

ABSTRACT

The positive detection during partum labor makes women weak and generates specific care demands. The aim of this research was to analyze professional care to women with positive result from fast HIV test based on the point of view of women who knew the positive result during partum labor or postpartum. This is an exploratory study with a qualitative approach. Data were collected through semi-structured interviews and analyzed using the discourse analysis technique. It was observed that the relations of care for women with positive rapid HIV test are far away from integrality, since they remain distant and superficial, being guided by the biomedical model. The mainstreaming of integrality in health care requires consideration by the professional, public health system managers, as well as training of those professionals.


Subject(s)
HIV Seropositivity/therapy , Patient Satisfaction , Delivery of Health Care, Integrated , Female , HIV Seropositivity/diagnosis , Humans , Peripartum Period , Postpartum Period , Pregnancy
10.
J Altern Complement Med ; 19(4): 334-40, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23098696

ABSTRACT

OBJECTIVES: The study objectives were to determine whether massage therapy reduces symptoms of depression in subjects with human immunodeficiency virus (HIV) disease. DESIGN: Subjects were randomized non-blinded into one of three parallel groups to receive Swedish massage or to one of two control groups, touch or no intervention for eight weeks. SETTINGS/LOCATION: The study was conducted at the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, California, which provided primary clinical care in an institutional setting. SUBJECTS: Study inclusion required being at least 16 years of age, HIV-seropositive, with a diagnosis of major depressive disorder. Subjects had to be on a stable neuropsychiatric, analgesic, and antiretroviral regimen for >30 days with no plans to modify therapy for the duration of the study. Approximately 40% of the subjects were currently taking antidepressants. All subjects were medically stable. Fifty-four (54) subjects were randomized, 50 completed at least 1 week (intent-to-treat; ITT), and 37 completed the study (completers). INTERVENTIONS: Swedish massage and touch subjects visited the massage therapist for 1 hour twice per week. The touch group had a massage therapist place both hands on the subject with slight pressure, but no massage, in a uniform distribution in the same pattern used for the massage subjects. OUTCOME MEASURES: The primary outcome measure was the Hamilton Rating Scale for Depression score, with the secondary outcome measure being the Beck Depression Inventory. RESULTS: For both the ITT and completers analyses, massage significantly reduced the severity of depression beginning at week 4 (p ≤ 0.04) and continuing at weeks 6 (p ≤ 0.03) and 8 (p ≤ 0.005) compared to no intervention and/or touch. CONCLUSIONS: The results indicate that massage therapy can reduce symptoms of depression in subjects with HIV disease. The durability of the response, optimal "dose" of massage, and mechanisms by which massage exerts its antidepressant effects remain to be determined.


Subject(s)
Depression/therapy , Depressive Disorder/therapy , HIV Seropositivity/therapy , Massage , Adult , Antidepressive Agents/therapeutic use , Depression/complications , Depressive Disorder/complications , Female , HIV Seropositivity/complications , Humans , Male , Middle Aged , Severity of Illness Index , Therapeutic Touch
11.
Curr HIV/AIDS Rep ; 9(4): 351-63, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22933247

ABSTRACT

Food insecurity, micronutrient deficits, dyslipidemia, insulin resistance, obesity, cardiovascular disease, and bone disorders complicate the treatment of HIV infection. Nutrition and exercise interventions can be effective in ameliorating these symptoms that are associated with HIV and antiretroviral therapy (ART). In this literature review, we examine the most recent nutrition and exercise interventions for HIV-infected patients. Macronutrient supplementation can be useful in treating malnutrition and wasting. Multivitamin (vitamin B complex, vitamin C, and vitamin E) supplements and vitamin D may improve quality of life and decrease morbidity and mortality. Nutritional counseling and exercise interventions are effective for treating obesity, fat redistribution, and metabolic abnormalities. Physical activity interventions improve body composition, strength, and fitness in HIV-infected individuals. Taken collectively, the evidence suggests that a proactive approach to nutrition and physical activity guidance and interventions can improve outcomes and help abrogate the adverse metabolic, cardiovascular, and psychological consequences of HIV and its treatments.


Subject(s)
Acquired Immunodeficiency Syndrome/therapy , Dyslipidemias/prevention & control , Exercise , HIV Seropositivity/therapy , Malnutrition/prevention & control , Obesity/prevention & control , Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/immunology , Acquired Immunodeficiency Syndrome/physiopathology , Bone Density , Chronic Disease , Dietary Supplements , Disease Progression , Dyslipidemias/complications , Dyslipidemias/immunology , Female , HIV Seropositivity/complications , HIV Seropositivity/immunology , HIV Seropositivity/physiopathology , Humans , Insulin Resistance/immunology , Male , Malnutrition/complications , Malnutrition/immunology , Nutritional Status , Obesity/complications , Obesity/immunology , Quality of Life , Vitamins/therapeutic use
13.
Rev Med Inst Mex Seguro Soc ; 47(6): 651-8, 2009.
Article in Spanish | MEDLINE | ID: mdl-20602905

ABSTRACT

OBJECTIVE: To evaluate the use of complementary alternative medicine (CAM) in patients infected with the human immunodeficiency virus (HIV), and to identify the type and factors associated to its use. METHODS: Cross-sectional study made in HIV clinics of three majors institutions from Morelos State, Mexico; the sample was 293 subjects; a specific questionnaire looking for demographic information and CAM use was applied. RESULTS: The use of CAM was 73.4%; 71% informed to the physician of their use. 51% of the patients reported using nutritional complements, 29.7% herbal products and 19% used physical agents like exercise, Chinese medicine, and therapy by contact. A total of 96.6 % of the users reported some perception of benefit with its use. The patients with low income, IMSS beneficiaries and on antirretroviral treatment were the greatest CAM users. CONCLUSIONS: CAM use is a common practice among HIV (+) patients. The multivitamins and herbal products were the most used. The majority was prescribed by health personnel and the users showed some benefit. Other longitudinal studies are required to establish the CAM impact on the disease evolution and the quality of life of HIV (+) patients.


Subject(s)
Complementary Therapies/statistics & numerical data , HIV Seropositivity/therapy , Adolescent , Adult , Aged , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Young Adult
14.
AIDS Care ; 20(8): 1002-18, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18608078

ABSTRACT

Use of complementary and alternative medicine (CAM) is prevalent among HIV-positive individuals despite the success of antiretroviral treatments and limited evidence of CAM's safety and efficacy. To characterize the potential impact of CAM use on HIV care, we conducted a systematic review of 40 studies of CAM use among HIV-positive people. The goals of this review are to: (1) describe the demographic, biomedical, psychosocial and health behavior correlates of CAM use; (2) characterize patient-reported reasons for CAM use; and (3) identify methodological and conceptual limitations of the reviewed studies. Findings confirm that a high proportion of HIV-positive individuals report CAM use (M=60%). Overall, CAM use is more common among HIV-positive individuals who are men who have sex with men (MSM), non-minority, better educated and less impoverished. The use of CAM is also associated with greater HIV-symptom severity and longer disease duration. HIV-positive CAM users commonly report that they use CAM to prevent or alleviate HIV-related symptoms, reduce treatment side-effects and improve quality of life. Findings regarding the association between CAM use, psychosocial adjustment and adherence to conventional HIV medications are mixed. While the reviewed studies are instrumental in describing the characteristics of HIV-positive CAM users, this literature lacks a conceptual framework to identify causal factors involved in the decision to use CAM or explain implications of CAM use for conventional HIV care. To address this concern, we propose the use of health behavior theory and discuss implications of review findings for HIV care providers.


Subject(s)
Anti-HIV Agents/therapeutic use , Complementary Therapies/statistics & numerical data , HIV Seropositivity/therapy , Attitude to Health , Complementary Therapies/methods , HIV Seropositivity/psychology , Humans , Patient Satisfaction
15.
AIDS Behav ; 8(4): 453-62, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15690118

ABSTRACT

Child sexual abuse (CSA) is associated with HIV risk behaviors [Bensley, L., Van Eenwyk, J., and Simmons, K. W., 2003.] and more prevalent among women living with HIV than in the general population [Koenig, L. J., and Clark, H., 2004]. This randomized Phase~I clinical trial tested the impact of a culturally congruent psychoeducational intervention designed to reduce sexual risks and increase HIV medication adherence for HIV-positive women with CSA histories. An ethnically diverse sample of 147 women were randomized to two conditions: an 11-session Enhanced Sexual Health Intervention (ESHI) or an attention control. Results based on "intent to treat'' analyses of pre-post changes are reported here. Additional analyses explored whether the observed effects might depend on "intervention dose,'' i.e., number of sessions attended. Women in the ESHI condition reported greater sexual risk reduction than women in the control condition. Although there were no differences between women in the ESHI and control groups on medication adherence, women in the ESHI condition who attended 8 or more sessions reported greater medication adherence at posttest than control women. The findings provide initial support for this culturally and gender-congruent psychoeducational intervention for HIV-positive women with CSA, and highlight the importance of addressing the effects of CSA on sexual risk reduction and medication adherence in preventive interventions for women.


Subject(s)
Anti-HIV Agents/therapeutic use , Child Abuse, Sexual/statistics & numerical data , Cognitive Behavioral Therapy/methods , HIV Seropositivity/therapy , Risk Reduction Behavior , Social Support , Adult , CD4 Antigens/immunology , CD8 Antigens/immunology , Child , Child Abuse, Sexual/ethnology , Combined Modality Therapy , Culture , Enzyme-Linked Immunosorbent Assay , Female , HIV Seropositivity/ethnology , HIV Seropositivity/immunology , Humans , Patient Compliance/statistics & numerical data , Preventive Health Services/supply & distribution , Women's Health Services/supply & distribution
16.
Transfusion ; 43(7): 963-73, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12823758

ABSTRACT

BACKGROUND: An association between allogeneic blood transfusion (ABT) and mortality was reported by one team of investigators from randomized controlled trials (RCTs) comparing recipients of non-WBC-reduced versus WBC-reduced RBCs in open-heart surgery. A meta-analysis was undertaken to examine whether this finding can be generalized across clinical settings and/or transfused RBC components. STUDY DESIGN AND METHODS: RCTs reporting on adverse immunomodulatory effects of ABT between January 1992 and August 2002 were retrieved. Fourteen studies had recorded mortality as a primary or secondary outcome and met all other criteria for meta-analysis. Summary ORs of mortality in a treatment arm receiving WBC-containing allogeneic RBCs versus a control arm receiving autologous or WBC-reduced allogeneic RBCs were calculated across studies, for groups of studies in which the hypothesis of homogeneity was not rejected. RESULTS: There was no association between ABT and mortality across 14 RCTs reporting on short-term mortality (summary OR, 1.20; 95% CI, 0.87-1.65) or across 3 RCTs reporting on long-term mortality (summary OR, 0.87; 95% CI, 0.64-1.19). In subgroup analyses, RCTs using autologous blood or conducted in abdominal or vascular surgery showed no difference in mortality, but short-term mortality differed across 3 RCTs conducted in open-heart surgery (summary OR, 2.26; 95% CI, 1.31-3.90; p < 0.05) and 7 RCTs comparing recipients of non-WBC-reduced versus WBC-reduced allogeneic RBCs filtered before storage (summary OR, 1.45; 95% CI, 1.00-2.11; p >/= 0.05). CONCLUSIONS: An association between ABT and either short-term or long-term mortality was not detected across clinical settings and transfused RBC components, but subgroup analyses suggest that an association between WBC-containing ABT and short-term mortality may exist in open-heart surgery and in settings where WBC-reduced allogeneic RBCs filtered before storage are administered.


Subject(s)
Blood Component Removal , Erythrocyte Transfusion/mortality , Leukocytes , Randomized Controlled Trials as Topic , Blood Transfusion, Autologous , Cardiac Surgical Procedures/mortality , Colorectal Neoplasms/surgery , HIV Seropositivity/therapy , Humans , Odds Ratio , Transplantation, Homologous , Vascular Surgical Procedures
17.
Soc Sci Med ; 52(11): 1643-59, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11327138

ABSTRACT

The purpose of this study is to characterize the relationship between identity and health care experiences (including antiretroviral therapy utilization) among HIV-positive sexual minority males. This qualitative study used grounded theory with data collection occurring through focus groups and interviews. A questionnaire was used to complete a demographic profile. The study included 47 HIV positive participants from three minorities: gay men, bisexual men and transgendered persons, gender identifying as female and or living as women. Sessions elicited information on: (1) general experiences with health care, (2) experiences with HIV antiretroviral therapies and issues surrounding access, and (3) adherence to these therapies and identity in relation to health care. These textual data revealed three themes: (1) the importance of sexual identity and its social and cultural context, (2) the differences in the health concerns between the sexual minorities and (3) a wide spectrum of experiences with the health care system that provide information surrounding the access to and adequacy of health care. Successful health care providers are aware of different issues that may play a role in the provision of health care to these sexual minorities. Providers awareness of sexual and social identity and the related different cultural values, beliefs and custom enhance care seeking and therapeutic adherence. For sexual minorities, primary care remains the most important entry point into the health care system. Cultural competence of care providers can foster patient's care seeking and adherence to treatment.


Subject(s)
Attitude of Health Personnel , Bisexuality/psychology , Clinical Competence/standards , Gender Identity , HIV Seropositivity/ethnology , Holistic Health , Homosexuality, Male/psychology , Minority Groups/psychology , Patient Acceptance of Health Care/ethnology , Prejudice , Self Concept , Transsexualism/psychology , Adult , British Columbia , Focus Groups , HIV Seropositivity/therapy , Humans , Male , Professional-Patient Relations , Surveys and Questionnaires , Truth Disclosure
18.
J Altern Complement Med ; 5(5): 447-56, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10537244

ABSTRACT

OBJECTIVE: To examine frequency and correlates of physicians' reports of discussions with patients with human immunodeficiency virus (HIV) about complementary and alternative medical (CAM) therapies. DESIGN: Mailed physician survey. SETTING: The setting was Eastern Massachusetts. PARTICIPANTS: Participants included 89 physicians caring for patients with HIV. MEASUREMENTS AND MAIN RESULTS: Physicians were asked how common the use of CAM therapies was among their patients, how useful these therapies were, how often they discussed the use of CAM therapies with new and follow-up patients, and whether they had used a CAM therapy themselves in the last year. We also collected information on physicians' sociodemographic and practice characteristics. Sixty-eight percent (89/130) of physicians responded, and 26% and 5% reported discussing CAM therapies with HIV-infected patients at most new and follow-up visits, respectively. Respondents' attitudes toward the use of CAM therapies were generally positive, and they believed their HIV-infected patients used CAM therapies more than their non-HIV infected patients. The majority (63%) believed that CAM therapies may be helpful for HIV-infected patients. Thirty-six percent (36%) had used a CAM therapy themselves in the last year. In multivariate analyses, only the belief that CAM therapies are helpful was correlated with discussion of CAM therapies (p = 0.006). Respondents' demographic characteristics, training, personal use of CAM therapies, reported visit length, and satisfaction with visit length were not associated with discussion of CAM therapies. CONCLUSIONS: Despite awareness that their HIV-infected patients commonly use CAM therapies and positive attitudes towards such therapies, most of these physicians did not routinely discuss CAM therapies with them. Barriers to physician-patient communication about CAM therapies merit further investigation.


Subject(s)
Communication , Complementary Therapies , HIV Seropositivity/therapy , Physician-Patient Relations , Surveys and Questionnaires , Adult , Female , Follow-Up Studies , Humans , Male , Middle Aged
19.
Ann Ist Super Sanita ; 35(4): 489-97, 1999.
Article in Italian | MEDLINE | ID: mdl-10721217

ABSTRACT

The national trends of the utilisation of non conventional therapies suggest that an increasing number of patients employ remedies that are outside the mainstream of what has been defined as conventional western medicine. The extent to which these practices have clinical efficacy according to biomedical criteria is a matter of ongoing debate. It may be that independent of any such efficacy, the attraction of alternative medicine is related to the power of its underline shared beliefs and cultural assumptions. The fundamental premises are an advocacy of nature, vitalism, "science" and spirituality. For patients, who choose alternative medicine, the most important reason to abandon conventional therapies could be to move from the sterile "high-tech" realm of official medicine to a more intimate "high-touch" intervention offered by non-physicians.


Subject(s)
Complementary Therapies/statistics & numerical data , Diffusion of Innovation , Acquired Immunodeficiency Syndrome/therapy , Australia , Canada , Europe , HIV Seropositivity/therapy , HIV-1/immunology , Humans , Japan , Neoplasms/therapy , United States
20.
Chin Med Sci J ; 14(4): 224-8, 1999 Dec.
Article in English | MEDLINE | ID: mdl-12894896

ABSTRACT

OBJECTIVE: To determine whether malariotherapy (an old therapy for treatment of neurosyphilis) improves some clinical and laboratory parameters of HIV-positive patients without iatrogenic complications. METHODS: Total 8 asymptomatic HIV-1 positive subjects whose CD4 cell counts were over 250 x 10(6) cells/L were selected for the phase-1 studies of malariotherapy and were intravenously injected Plasmodia vivax to induce artificial malaria. Malaria was terminated with chloroquine after 10 to approximately 20 malarial fever episodes. Cell-bound CD4 levels were measured by APAAP (a solid-phase enzyme essay) and levels of neopterin (NPT), beta-2-microglobulin (B2M), soluble tumor necrosis factor receptor-2 (sTNF-RII), interleukin-2 (IL-2) and HIV P24 antigen were measured by ELISA. Patients were followed up to 24 to approximately 30 months. RESULTS: CD4 levels increased in 5, NPT decreased in 7 of 8 patients; IL-2 increased in 5 of 6 patients after malariotherapy. The total trends of B2M and sTNF-RII basically remained stable. HIV P24 antigen remained undetectable in 6, remained detectably low level in 1 and experienced increase in 1 of 8 patients after malariotherapy. No any severe complications occurred in all 8 patients. CONCLUSIONS: The results indicate that malariotherapy basically is safe for HIV infection and it seems that the therapy improves some immunological parameters of HIV patients.


Subject(s)
HIV Infections/therapy , HIV Seropositivity/therapy , Hyperthermia, Induced , Malaria , Adult , Animals , CD4 Lymphocyte Count , Follow-Up Studies , HIV Core Protein p24/blood , HIV Infections/immunology , HIV Infections/parasitology , HIV Seropositivity/immunology , HIV Seropositivity/parasitology , Humans , Malaria/immunology , Male , Neopterin/blood , Plasmodium vivax , Receptors, Tumor Necrosis Factor/blood , beta 2-Microglobulin/blood
SELECTION OF CITATIONS
SEARCH DETAIL